Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement
Valvular disease remains a major cause of cardiovascular morbidity and mortality worldwide. Over the past decade, catheter-based interventions in valvular disease have evolved from balloon dilation of native stenotic valves to repair of paravalvular regurgitation (PVR) with vascular plugs and more recently to valve replacement and repair. Currently-approved interventions include transcatheter aortic valve replacement (TAVR), pulmonic valve replacement, and mitral valve repair, targeted to specific populations. Rapid technological advancements in device design are likely to improve acute and long-term results and expand current indications.
Authors
Published Date
April 1, 2019
Source
JASE
Topic
- Guidelines
Language
- English
- Spanish
Technique
- 3D Echocardiography (3DE)
- Interventional Echocardiography (IE)
- Multimodality (MM)
- Pulsed Echo Doppler Flow (PEDOF)
- Transcatheter Aortic Valve Implantation (TAVI)
- Transcatheter Aortic Valve Replacement (TAVR)
- Transcatheter Mitral Valve Replacement (TMVR)
- Transesophageal Echo (TEE)
- Transthoracic Echo (TTE)
Disease
- Aortic Regurgitation (AR)
- Aortic Stenosis (AS)
- Left Ventricular Outflow Tract ( LVOT)
- Mitral Regurgitation (MR)
- Mitral Stenosis (MS)
- Paravalvular Leak (PVL)
- Rheumatic Heart Disease (RHD)
- Right Ventricular Outflow Tract (RVOT)
- Structural Heart Disease (SHD)
- Tricuspid Regurgitation (TR)
- Valvular Heart Disease (VHD)
Anatomy
- Aortic Valve (AV)
- Mitral Valve (MV)
- Tricuspid Valve (TV)
Audience
- Fellows in Training
- Industry Partners
- Physicians
- Sonographer Students
- Sonographers